155 related articles for article (PubMed ID: 5514626)
1. An evaluation of combination chemotherapy with procarbazine (NSC-77213) and 5-fluorouracil (NSC-19893) in advanced carcinoma of the lung.
Gottlieb JA; Serpick AA
Cancer Chemother Rep; 1970 Oct; 54(5):369-71. PubMed ID: 5514626
[No Abstract] [Full Text] [Related]
2. Clinical evaluation of procarbazine and fluorouracil in advanced lung cancer.
Pacilio G; Puzziello T
Bronches; 1971; 21(4):402. PubMed ID: 4340778
[No Abstract] [Full Text] [Related]
3. [Cytostatic therapy of tumors of the lung].
De Marco F; Saviano G; Tenore G
Arch Monaldi; 1974; 29(3-4):326-35. PubMed ID: 4463917
[No Abstract] [Full Text] [Related]
4. [Prognostic factors in the chemotherapy of bronchial cancers].
Alberto P
Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
[No Abstract] [Full Text] [Related]
5. Radiation plus 5-fluorouracil (NSC-19893): clinical demonstration of an additive effect in bronchogenic carcinoma.
Cohen JL; Krant MJ; Shnider BI; Matias PI; Horton J; Baxter D
Cancer Chemother Rep; 1971 Jun; 55(3):253-8. PubMed ID: 5115846
[No Abstract] [Full Text] [Related]
6. Combination chemotherapy of bronchogenic carcinoma with cyclophosphamide (NSC-26271) and BCNU (NSC-409962).
Curtis JE
Cancer Chemother Rep; 1974; 58(6):883-8. PubMed ID: 4614897
[No Abstract] [Full Text] [Related]
7. Chemotherapy of lung cancer: the experience of the National Cancer Institute of Milan.
Bonadonna G; Tancini G; Bajetta E
Cancer Chemother Rep 3; 1973 Mar; 4(2):231-7. PubMed ID: 4125741
[No Abstract] [Full Text] [Related]
8. Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinoma.
Lanzotti VJ; Thomas DR; Holoye PY; Boyle LE; Smith TL; Samuels ML
Cancer Treat Rep; 1976 Jan; 60(1):61-8. PubMed ID: 63331
[TBL] [Abstract][Full Text] [Related]
9. A randomized study comparing irradiation alone to irradiation plus procarbazine in inoperable bronchogenic carcinoma.
Landgren RC; Hussey DH; Samuels ML; Leary WV
Radiology; 1973 Aug; 108(2):403-6. PubMed ID: 4578183
[No Abstract] [Full Text] [Related]
10. Heparin anticoagulation as adjuvant to chemotherapy in carcinoma of the lung.
Elias EG
J Med; 1974; 5(1):114-32. PubMed ID: 4364885
[No Abstract] [Full Text] [Related]
11. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.
Bitran JD; Desser RK; DeMeester TR; Colman M; Evans R; Billings A; Griem M; Rubenstein L; Shapiro C; Golomb HM
Cancer Treat Rep; 1976 Sep; 60(9):1225-30. PubMed ID: 189920
[TBL] [Abstract][Full Text] [Related]
12. Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
Bitran JD; Desser RK; DeMeester T; Golomb HM
JAMA; 1978 Dec; 240(25):2743-6. PubMed ID: 713008
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy with methyl-CCNU (NSC-95441), cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and bleomycin (NSC-125066) in advanced bronchogenic carcinoma.
McMahon LJ; Jones SE; Durie BG; Salmon SE
Cancer Lett; 1975 Nov; 1(2):97-102. PubMed ID: 65213
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for lung cancer at the Institute of Experimental and Clinical Oncology, Academy of Medical Sciences, USSR.
Perevodchikova NI; Bychkov MB
Cancer Chemother Rep 3; 1973 Mar; 4(2):251-5. PubMed ID: 4199645
[No Abstract] [Full Text] [Related]
15. Phase II study of the effect of methyl-CCNU (NSC-95441) on bronchogenic carcinoma.
Takita H; Brugarolas A; Mittelman A; Vincent R
Cancer Chemother Rep 3; 1973 Mar; 4(2):257-9. PubMed ID: 4125743
[No Abstract] [Full Text] [Related]
16. [Chemotherapy in advanced cancer of the lung].
Fleischer I; Wainstein R; Jovtis SL; Gibson AM; Barousse AP
Medicina (B Aires); 1979; 39(4):472-6. PubMed ID: 545078
[No Abstract] [Full Text] [Related]
17. Chemotherapy of inoperable bronchogenic carcinoma.
Behera D; Malik SK
Indian J Chest Dis Allied Sci; 1985; 27(3):175-89. PubMed ID: 3017850
[No Abstract] [Full Text] [Related]
18. 5-Fluorouracil (NSC-19893) compared to cyclophosphamide (NSC-26271) in bronchogenic carcinoma: results of a clinical study.
Brugarolas A; Rivas A; Lacave AJ; Gonzalez-Palacois F; Froufe A
Cancer Chemother Rep; 1975; 59(5):1025-6. PubMed ID: 1106844
[No Abstract] [Full Text] [Related]
19. [Chemotherapy of the non-small cell bronchogenic carcinoma].
Dimitriadis K; Boutis L; Tavantzis J; Mouratidou D; Bouchoris N; Koukourikos S; Hatzigogos K; Safarini S
Onkologie; 1983 Feb; 6(1):8-10. PubMed ID: 6189039
[TBL] [Abstract][Full Text] [Related]
20. Role of a nitrosourea (CCNU, NSC-79037) in advanced nonhematologic cancer.
Perloff M; Muggia FM; Ackerman C
Cancer Chemother Rep; 1974; 58(3):421-4. PubMed ID: 4841718
[No Abstract] [Full Text] [Related]
[Next] [New Search]